STOCK TITAN

ViewRay Inc. - VRAY STOCK NEWS

Welcome to our dedicated news page for ViewRay (Ticker: VRAY), a resource for investors and traders seeking the latest updates and insights on ViewRay.

Our selection of high-quality news articles is accompanied by an expert summary from Rhea-AI, detailing the impact and sentiment surrounding the news at the time of release, providing a deeper understanding of how each news could potentially affect ViewRay's stock performance. The page also features a concise end-of-day stock performance summary, highlighting the actual market reaction to each news event. The list of tags makes it easy to classify and navigate through different types of news, whether you're interested in earnings reports, stock offerings, stock splits, clinical trials, fda approvals, dividends or buybacks.

Designed with both novice traders and seasoned investors in mind, our page aims to simplify the complex world of stock market news. By combining real-time updates, Rhea-AI's analytical insights, and historical stock performance data, we provide a holistic view of ViewRay's position in the market.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-2.07%
Tags
none
-
Rhea-AI Summary
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-3.57%
Tags
none
-
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
3.85%
Tags
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-- %
Tags
none
-
-
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-3.15%
Tags
management
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
8.67%
Tags
-
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
8.67%
Tags
none
-
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
1.35%
Tags
none
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
0.45%
Tags
conferences
ViewRay Inc.

Nasdaq:VRAY

VRAY Rankings

VRAY Stock Data

Surgical and Medical Instrument Manufacturing
Manufacturing
Link
US
Oakwood Village

About VRAY

mri-guided adaptive radiotherapy viewray®, inc. (nasdaq:vray), designs, manufactures, and markets the mridian® radiation therapy system to address the key limitations of existing external-beam radiation therapy technologies. mridian employs mri-based technology to provide real-time imaging that clearly defines the targeted tumor from the surrounding soft tissue and other critical organs during radiation treatment. mridian allows physicians to record the level of radiation exposure that the tumor has received and adapt the prescription as needed. viewray believes this combination of enhanced visualization, on-line adapting and accurate dose recording will significantly improve the safety and efficacy of radiation therapy, leading to better outcomes for patients. at viewray, our vision is clear. we’re dedicated to giving doctors new and better ways to treat cancer with radiation therapy. we’re an entrepreneurial company with big ambitions, unlimited potential and a passion for improving